PURE Bioscience, Inc. (PURE)

Market Cap	7.61M
Revenue (ttm)	2.09M
Net Income (ttm)	-3.63M
Shares Out	111.86M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Open	0.0680
Previous Close	0.0620
Day's Range	n/a
52-Week Range	0.0600 - 0.1700
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 14, 2023

About PURE

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control,...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• IPO Date: Aug 8, 1996
• Employees: 11
• Stock Exchange: OTCMKTS
• Ticker Symbol: PURE

Financial Performance

In 2023, PURE's revenue was $1.88 million, an increase of 1.30% compared to the previous year's $1.85 million. Losses were -$3.96 million, 13.3% more than in 2022.